Autopsy report · NCT00032084

S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery

“This study was closed early due to poor accrual”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months after it had already started.
• Ran for about 2 years 1 month before it stopped.
• 10 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

SWOG Cancer Research Network

Sponsor type

University, hospital or other

Conditions

Lung Cancer

Interventions

smoking cessation intervention; bupropion hydrochloride; nicotine; psychosocial assessment and care

Participants

10

Sites

176

Countries

Puerto Rico, United States

Trials that died the same way

• High Dose Rate Brachyablation of Primary Liver Lesions
  “Study was closed due to poor accrual” (90% match in meaning)
• Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer
  “Study was closed to low accrual.” (90% match in meaning)
• Ibrutinib, Nivolumab and Blinatumomab in Richter Transformation
  “The study was closed for slow accrual” (87% match in meaning)
• Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies
  “accrual was slow and sporadic so the study was closed” (87% match in meaning)
• Pre-operative Zoledronate in Triple Negative Breast Cancer
  “The study stopped prematurely due to the low accrual rate” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.